RE:RE:RE:RE:RE:NothingExcellent post. The timelines you lay out are realistic and very credible. And your advice to hang tight is very prescient. Based on the science and the clinic, this will be a very different company - in a good way - a mere two years out.
stocksnbonds458 wrote: Agreed skys1, other than Dr Sherri the management and supporting cast are a bit of a gong show (refer to Phase 2 F-ups for clarification per said non-technical terminology). In spite of the assembled "Dream Team" her breakthrough will win out in the end. IMO we have an almost 2 year wait for "Breakthrough" FDA approval once we have our 20-25 phase 2 patients enrolled with which to collect the required data. So the 450 day clock starts ticking when we reach this critical number of enrolled phase 2 participants. Let's say the clock starts ticking Sept 1 at best. So 60 days from now, + 450 day data accumulation time + 60 days FDA approval time = 570 days from now. That works out to Feb 2023 if all goes well. Keep in mind they can apply for Breakthrough Status at any time during the 450 days, but for the purposes of this time-line I am assuming they won't jump the gun and submit incomplete data. I have been waiting 6 years, a few more won't kill me i quess.